The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of around 25 per cent on pharmaceutical, automobile, and semiconductor imports
Stocks such as Natco, Dr. Reddy's, Cipla, Mankind, Torrent, Sun Pharma, Abbott, and Glenmark slipped in the range of 1-2 per cent
The company's revenue from operations increased to Rs 3,374 crore in Q3 FY25, a marginal 1.5 per cent Y-o-Y rise from Rs 3,324 crore in Q3 FY24
The company along with its arm will acquire a 26 per cent stake in the Capital of Sunsure Solarpark
Individually, Cipla soared up to 3.68 per cent to hit an intraday high of Rs 1,547.70 per share, while Sun Pharma soared up to 3.30 per cent to hit an intraday high of Rs 1,791.60 per share
Technical charts indicate that the 5 newly added stocks to the MSCI index are favourably placed and could soar up to 19% in forthcoming trading sessions.